Cardiovascular

  • 15 January 2020
    whitepapers

    Case Study: Bristol-Myers Squibb

    Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with serious diseases.

  • 3 January 2020
    Analysis

    2019 top news stories

    BMS acquires Celgene for an equity value of $74bn and GSK signs $4.2bn immunotherapy deal with the Merck group. Pharmaceutical-technology.com wraps up key headlines from 2019.

Close
Close
Close

Go Top